PT2635583E - Derivados da coelenterazina e métodos de utilização da mesma - Google Patents

Derivados da coelenterazina e métodos de utilização da mesma Download PDF

Info

Publication number
PT2635583E
PT2635583E PT117852178T PT11785217T PT2635583E PT 2635583 E PT2635583 E PT 2635583E PT 117852178 T PT117852178 T PT 117852178T PT 11785217 T PT11785217 T PT 11785217T PT 2635583 E PT2635583 E PT 2635583E
Authority
PT
Portugal
Prior art keywords
methods
same
coelenterazine derivatives
coelenterazine
derivatives
Prior art date
Application number
PT117852178T
Other languages
English (en)
Portuguese (pt)
Inventor
Dieter H Klaubert
Poncho Meisenheimer
James Unch
Wenhui Zhou
Original Assignee
Promega Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Promega Corp filed Critical Promega Corp
Publication of PT2635583E publication Critical patent/PT2635583E/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/02Heterocyclic radicals containing only nitrogen as ring hetero atoms
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/66Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving luciferase

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
PT117852178T 2010-11-02 2011-11-02 Derivados da coelenterazina e métodos de utilização da mesma PT2635583E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US40941310P 2010-11-02 2010-11-02

Publications (1)

Publication Number Publication Date
PT2635583E true PT2635583E (pt) 2015-09-11

Family

ID=44999921

Family Applications (1)

Application Number Title Priority Date Filing Date
PT117852178T PT2635583E (pt) 2010-11-02 2011-11-02 Derivados da coelenterazina e métodos de utilização da mesma

Country Status (15)

Country Link
US (1) US9487520B2 (cg-RX-API-DMAC7.html)
EP (1) EP2635583B1 (cg-RX-API-DMAC7.html)
JP (1) JP6040157B2 (cg-RX-API-DMAC7.html)
KR (1) KR101968475B1 (cg-RX-API-DMAC7.html)
CN (1) CN103180324A (cg-RX-API-DMAC7.html)
AU (1) AU2011323455B2 (cg-RX-API-DMAC7.html)
BR (1) BR112013010484B1 (cg-RX-API-DMAC7.html)
CA (1) CA2815381C (cg-RX-API-DMAC7.html)
DK (1) DK2635583T3 (cg-RX-API-DMAC7.html)
ES (1) ES2543913T3 (cg-RX-API-DMAC7.html)
IL (1) IL225869A (cg-RX-API-DMAC7.html)
PL (1) PL2635583T3 (cg-RX-API-DMAC7.html)
PT (1) PT2635583E (cg-RX-API-DMAC7.html)
SG (1) SG189494A1 (cg-RX-API-DMAC7.html)
WO (1) WO2012061477A1 (cg-RX-API-DMAC7.html)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG189494A1 (en) 2010-11-02 2013-05-31 Promega Corp Coelenterazine derivatives and methods of using same
EP3498709B1 (en) 2010-11-02 2025-12-31 Promega Corporation Luciferases from Oplophorus: Novel Coelenterazine Substrates and Their Methods of Use
JP6067019B2 (ja) 2011-09-02 2017-01-25 プロメガ コーポレイションPromega Corporation 代謝的に活性な細胞の酸化還元状態を評価するための化合物及び方法、ならびにnad(p)/nad(p)hを測定するための方法
EP2900833B1 (en) 2012-09-26 2018-05-30 Promega Corporation Real-time monitoring
US20140271460A1 (en) 2013-03-15 2014-09-18 G1 Therapeutics, Inc. Highly Active Anti-Neoplastic and Anti-Proliferative Agents
ES2761406T3 (es) 2013-03-15 2020-05-19 G1 Therapeutics Inc Protección transitoria de células normales durante una quimioterapia
JP6270127B2 (ja) * 2014-01-17 2018-01-31 国立研究開発法人物質・材料研究機構 ニコチンアデニンジヌクレオチド誘導体を検出する方法
WO2015116867A1 (en) * 2014-01-29 2015-08-06 Promega Corporation Quinone-masked probes as labeling reagents for cell uptake measurements
WO2015116806A1 (en) * 2014-01-29 2015-08-06 Promega Corporation Pro-substrates for live cell applications
WO2016210294A1 (en) 2015-06-25 2016-12-29 Promega Corporation Thienopyrrole compounds and uses thereof as inhibitors of oplophorus-derived luciferases
WO2017142852A1 (en) 2016-02-15 2017-08-24 Promega Corporation Coelenterazine analogues
WO2018022865A1 (en) 2016-07-28 2018-02-01 Promega Corporation Coelenterazine analogues
EP3510035B1 (en) * 2016-09-09 2021-04-07 Promega Corporation Dual protected pro-coelenterazine substrates
EP3535270B3 (en) 2016-11-01 2024-05-29 Promega Corporation Coelenterazine analogues tethered to energy acceptors
WO2018102693A1 (en) 2016-12-01 2018-06-07 Promega Corporation Cell impermeable coelenterazine analogues
JP7161475B2 (ja) 2016-12-28 2022-10-26 プロメガ コーポレイション 官能化nanoluc阻害剤
EP3395803A1 (en) * 2017-04-28 2018-10-31 Institut Pasteur Imidazopyrazine derivatives, process for preparation thereof, and their uses as luciferins
JP7419260B2 (ja) 2018-05-01 2024-01-22 プロメガ コーポレイション NanoLuc自殺基質としてのセレンテラジン化合物
EP4140991B1 (en) 2018-06-01 2024-05-15 Promega Corporation Inhibitors of oplophorus luciferase-derived bioluminescent complexes
KR102114088B1 (ko) * 2018-09-10 2020-06-17 (주)신우에이엔티 웨이퍼 세정용 나노 버블 분사 구조
CA3114424A1 (en) 2018-10-03 2020-04-09 Promega Corporation Compositions and methods for stabilizing coelenterazine and analogs and derivatives thereof
WO2021108765A1 (en) 2019-11-27 2021-06-03 Promega Corporation Multipartite luciferase peptides and polypeptides
US12061202B2 (en) 2019-12-10 2024-08-13 Promega Corporation Compositions and methods for bioluminescent detection using multifunctional probes

Family Cites Families (73)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3477549D1 (en) 1983-08-17 1989-05-11 Allied Signal Inc Gas generator and method of generating gas
JP3012274B2 (ja) * 1989-03-22 2000-02-21 日本臓器製薬株式会社 新規ルシフェリン誘導体
US5683888A (en) 1989-07-22 1997-11-04 University Of Wales College Of Medicine Modified bioluminescent proteins and their use
US5368484A (en) 1992-05-22 1994-11-29 Atari Games Corp. Vehicle simulator with realistic operating feedback
CA2157476C (en) 1994-01-03 2009-08-25 Keith V. Wood Mutant luciferases
US6387675B1 (en) 1994-01-03 2002-05-14 Promega Corporation Mutant luciferases
GB9501170D0 (en) 1994-03-23 1995-03-08 Secr Defence Luciferases
JP3648763B2 (ja) * 1994-08-23 2005-05-18 日本油脂株式会社 ウミホタルルシフェリン誘導体および糖加水分解酵素の定量方法
GB9417593D0 (en) 1994-09-01 1994-10-19 Secr Defence Luciferase labelling method
US5670356A (en) 1994-12-12 1997-09-23 Promega Corporation Modified luciferase
WO1996022376A1 (en) 1995-01-20 1996-07-25 The Secretary Of State For Defence Mutant luciferases
JPH08294397A (ja) 1995-04-27 1996-11-12 Nippon Oil & Fats Co Ltd 免疫学的活性物質の測定方法
US6522361B2 (en) 1996-03-08 2003-02-18 Sony Corporation Electronic apparatus having the function of displaying the battery residual quantity and method for displaying the battery residual quantity
JP4026876B2 (ja) * 1996-09-05 2007-12-26 日本食品化工株式会社 発光性シクロデキストリン誘導体及びその製造方法
US5998204A (en) 1997-03-14 1999-12-07 The Regents Of The University Of California Fluorescent protein sensors for detection of analytes
GB9707486D0 (en) 1997-04-11 1997-05-28 Secr Defence Enzyme assays
US6429286B1 (en) 1997-04-16 2002-08-06 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute Immunoregulatory molecules for costimulatory signal transduction
WO1999014336A2 (en) 1997-09-19 1999-03-25 Promega Corporation Thermostable luciferases and methods of production
US6602677B1 (en) 1997-09-19 2003-08-05 Promega Corporation Thermostable luciferases and methods of production
GB9823468D0 (en) 1998-10-28 1998-12-23 Secr Defence Novel enzyme
JP3694181B2 (ja) 1999-01-05 2005-09-14 キッコーマン株式会社 変異型ルシフェラーゼ、変異型ルシフェラーゼ遺伝子、新規な組み換え体dna及び変異型ルシフェラーゼの製造法
NZ518413A (en) 1999-10-26 2004-11-26 Secr Defence Novel enzyme
GB9925161D0 (en) 1999-10-26 1999-12-22 Secr Defence Novel enzyme
US20010046687A1 (en) 2000-03-31 2001-11-29 Dicesare Joseph L. Method for the enhancement of luminescence intensity from a reaction between adenosine triphosphate (ATP) and a luciferase/luciferin reactant system
DE60142761D1 (de) 2000-04-26 2010-09-23 Chisso Corp Oplophorus Luciferase
JP4613441B2 (ja) 2000-04-26 2011-01-19 チッソ株式会社 新規ルシフェラーゼおよび発光蛋白質
US7118878B1 (en) 2000-06-09 2006-10-10 Promega Corporation Method for increasing luminescence assay sensitivity
US7879540B1 (en) 2000-08-24 2011-02-01 Promega Corporation Synthetic nucleic acid molecule compositions and methods of preparation
JP2004508833A (ja) 2000-09-13 2004-03-25 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフトング バイオマスの検出および測定のための方法
US7268229B2 (en) 2001-11-02 2007-09-11 Promega Corporation Compounds to co-localize luminophores with luminescent proteins
CA2474695A1 (en) 2002-02-01 2003-08-14 Promega Corporation Bioluminescent protease assay
ATE513838T1 (de) 2002-09-20 2011-07-15 Promega Corp Auf lumineszenz basierende verfahren und sonden zur messung der cytochrom-p450-aktivität
EP1413584B1 (en) * 2002-10-21 2005-03-02 AXXAM S.r.l. Photoprotein with improved bioluminescence
CA2508072A1 (en) 2002-12-23 2004-07-15 Promega Corporation Protecting luciferase activity from luciferase enzyme interfering compounds using detergents for the accurate measurement of luciferase activity
DE10303265A1 (de) 2003-01-28 2004-07-29 Roche Diagnostics Gmbh Fluorimetrische Bestimmung von Analyten durch ein intramolekulares Quencher-Fluorophor-Konjugat
US7429472B2 (en) 2003-01-31 2008-09-30 Promega Corporation Method of immobilizing a protein or molecule via a mutant dehalogenase that is bound to an immobilized dehalogenase substrate and linked directly or indirectly to the protein or molecule
JP4748685B2 (ja) 2003-01-31 2011-08-17 プロメガ コーポレイション タンパク質に対する官能基の共有結合的テザリング
AU2004210982B2 (en) 2003-02-12 2008-12-18 Promega Corporation Methods and kits for dual enzymatic assays whereby light is quenched from luminescent reactions
US20040178545A1 (en) 2003-03-14 2004-09-16 Cates Larry E. System for optically analyzing a molten metal bath
CA2541765A1 (en) 2003-10-10 2004-10-01 Promega Corporation Luciferase biosensor
CA2552916C (en) 2004-01-08 2014-11-18 Universitat Zurich Metal complexes having vitamin b12 as a ligand
US7416854B2 (en) 2004-01-22 2008-08-26 Promega Corporation Luminogenic and nonluminogenic multiplex assay
US7553632B2 (en) 2004-01-22 2009-06-30 Promega Corporation Luminogenic and nonluminogenic multiplex assay
EP3179252B1 (en) 2004-07-30 2018-11-14 Promega Corporation Covalent tethering of functional groups to proteins and substrates therefor
US20070087400A1 (en) 2004-07-30 2007-04-19 Aldis Darzins Covalent tethering of functional groups to proteins and substrates therefor
US7425436B2 (en) 2004-07-30 2008-09-16 Promega Corporation Covalent tethering of functional groups to proteins and substrates therefor
US7728118B2 (en) 2004-09-17 2010-06-01 Promega Corporation Synthetic nucleic acid molecule compositions and methods of preparation
JP4453528B2 (ja) * 2004-10-26 2010-04-21 東京化成工業株式会社 新規化学発光試薬
EP1700865A1 (en) 2005-03-11 2006-09-13 AXXAM S.r.l. Photoproteins with enhanced bioluminescence and their use as intracellular calcium indicators
JP4639904B2 (ja) 2005-03-30 2011-02-23 チッソ株式会社 蛍光活性を有するルシフェラーゼの活性増強方法
JP3844082B2 (ja) 2005-04-08 2006-11-08 キッコーマン株式会社 耐熱性ホタルルシフェラーゼ、耐熱性ホタルルシフェラーゼ遺伝子、新規な組み換え体dna及び耐熱性ホタルルシフェラーゼの製造法
EP1935986B1 (en) 2005-05-31 2014-04-16 Promega Corporation Luminogenic and fluorogenic compounds and methods to detect molecules or conditions
EP2272972A1 (en) 2005-05-31 2011-01-12 Promega Corporation Luminogenic and fluorogenic compounds and methods to detect molecules or conditions
MX2008002123A (es) * 2005-08-17 2008-04-17 Yeda Res & Dev Metodos y composiciones para determinar un nivel de paraoxonasa de suero biologicamente activa.
JP4999341B2 (ja) 2005-09-06 2012-08-15 株式会社バイオエネックス 変異型ホタルルシフェラーゼ、遺伝子、組換えベクター、形質転換体、及び変異型ホタルルシフェラーゼの製造方法
CA2648263A1 (en) 2006-04-03 2007-10-25 Promega Corporation Permuted and nonpermuted luciferase biosensors
EP2843411B1 (en) 2006-10-24 2017-12-27 Gene Stream Pty Ltd. Luciferase signal enhancing compositions
WO2008054821A2 (en) 2006-10-30 2008-05-08 Promega Corporation Mutant hydrolase proteins with enhanced kinetics and functional expression
WO2008086035A2 (en) 2007-01-10 2008-07-17 Promega Corporation Split mutant hydrolase fusion reporter and uses thereof
US20080248511A1 (en) 2007-03-26 2008-10-09 Promega Corporation Methods to quench light from optical reactions
CN101849005A (zh) 2007-11-05 2010-09-29 普罗梅加公司 杂合融合报道子及其应用
JP6110591B2 (ja) 2008-05-19 2017-04-05 プロメガ コーポレイションPromega Corporation cAMPのためのルシフェラーゼバイオセンサー
EP2326953B1 (en) 2008-07-22 2018-03-21 Promega Corporation Adp detection based luminescent phosphotransferase or atp hydrolase assay
TWI354101B (en) 2008-08-19 2011-12-11 Univ Nat Taipei Technology Fluorimetric indicator for biosensing and manufact
WO2010119721A1 (ja) 2009-04-17 2010-10-21 独立行政法人産業技術総合研究所 超高輝度で安定な人工生物発光酵素
EP2456864B1 (en) 2009-05-01 2015-11-11 Promega Corporation Synthetic oplophorus luciferases with enhanced light output
WO2011038219A1 (en) 2009-09-24 2011-03-31 Promega Corporation Proteases having improved stability, solubility and activity
EP3508570B1 (en) 2010-05-11 2020-07-22 Promega Corporation Mutant protease biosensors with enhanced detection characteristics
EP2611929B1 (en) 2010-09-01 2016-01-13 Promega Corporation Oxidized glutathione assay
US9284188B2 (en) 2010-09-03 2016-03-15 The Regents Of The University Of California Cytosolic delivery of materials with endosome-disrupting colloids
EP3498709B1 (en) 2010-11-02 2025-12-31 Promega Corporation Luciferases from Oplophorus: Novel Coelenterazine Substrates and Their Methods of Use
SG189494A1 (en) 2010-11-02 2013-05-31 Promega Corp Coelenterazine derivatives and methods of using same
JP6067019B2 (ja) 2011-09-02 2017-01-25 プロメガ コーポレイションPromega Corporation 代謝的に活性な細胞の酸化還元状態を評価するための化合物及び方法、ならびにnad(p)/nad(p)hを測定するための方法

Also Published As

Publication number Publication date
KR101968475B1 (ko) 2019-04-15
PL2635583T3 (pl) 2015-11-30
CA2815381A1 (en) 2012-05-10
CA2815381C (en) 2019-03-19
BR112013010484B1 (pt) 2019-09-03
US9487520B2 (en) 2016-11-08
JP6040157B2 (ja) 2016-12-07
ES2543913T3 (es) 2015-08-25
DK2635583T3 (en) 2015-08-03
EP2635583A1 (en) 2013-09-11
US20120107849A1 (en) 2012-05-03
WO2012061477A1 (en) 2012-05-10
JP2013544242A (ja) 2013-12-12
KR20140003430A (ko) 2014-01-09
EP2635583B1 (en) 2015-06-03
IL225869A0 (en) 2013-07-31
SG189494A1 (en) 2013-05-31
AU2011323455B2 (en) 2017-07-27
AU2011323455A1 (en) 2013-05-30
BR112013010484A2 (pt) 2016-07-05
CN103180324A (zh) 2013-06-26
IL225869A (en) 2017-09-28

Similar Documents

Publication Publication Date Title
IL225869A (en) Colentrazine derivatives and methods for their use
EP2536283B8 (en) Phenyl-heteroaryl derivatives and methods of use thereof
IL225867A0 (en) New substrates of kolantrazin
IL222227A0 (en) Pyrazol - 4 - heterocyclyl-carboxamide compounds and methods of use
ZA201209205B (en) Pyridone and aza-pyridone compounds and methods of use
EP2539005A4 (en) ORAL PIECE AND METHODS OF USING THE SAME
LT3040424T (lt) Modifikuoti baltymai ir jų gavimo ir panaudojimo būdai
IL215251A0 (en) Atropisomers of2-purinyl-3-tolyl-quinazolinone derivatives and methods of use
IL220939A0 (en) Compounds and methods
IL223240A0 (en) Heteroaryl compounds and methods of use thereof
EP2523664A4 (en) COMPOUNDS AND METHODS
ZA201301120B (en) Heterocyclic compound and use thereof
IL236830A0 (en) Diazahomoredene derivatives and methods of using them
AP4055A (en) Dihydro-benzo-oxazine and dihydro-pyrido-oxazine derivatives
IL220812A0 (en) Compounds and methods
ZA201208948B (en) Modified beta-lactamases and methods and uses related thereto
ZA201300036B (en) Banzamide derivatives and their use as hsp90 inhibitors
EP2523560A4 (en) CONNECTIONS AND METHODS
EP2552267A4 (en) HAIRSTYLE, AND METHOD OF USE THEREOF
ZA201300174B (en) Anti-neuropilin antibodies and methods of use
ZA201203076B (en) Spirolactam derivatives and uses of same
IL229968A0 (en) Tetrazolyloxy derivatives and methods for their production
PL2694532T3 (pl) Pochodne aureobasidin i sposoby syntezy
WO2012045019A9 (en) Brca deficiency and methods of use
GB201003268D0 (en) Accessory system and method of use thereof